Relmada Therapeutics Announces Initiation of Second Pivotal Phase 3 Study of REL-1017 as …,

“We are pleased to begin enrolling patients into the second Phase 3 clinical trial of REL-1017 in MDD, a condition impacting more than 17 million …, “We are pleased to begin enrolling patients into the second Phase 3 clinical trial of REL-1017 in MDD, a condition impacting more than 17 million …, Read More

Scroll to Top